Literature DB >> 24231354

Immune response to RB1-regulated senescence limits radiation-induced osteosarcoma formation.

Maya Kansara, Huei San Leong, Dan Mei Lin, Sophie Popkiss, Puiyi Pang, Dale W Garsed, Carl R Walkley, Carleen Cullinane, Jason Ellul, Nicole M Haynes, Rod Hicks, Marieke L Kuijjer, Anne-Marie Cleton-Jansen, Philip W Hinds, Mark J Smyth, David M Thomas.   

Abstract

Ionizing radiation (IR) and germline mutations in the retinoblastoma tumor suppressor gene (RB1) are the strongest risk factors for developing osteosarcoma. Recapitulating the human predisposition, we found that Rb1+/- mice exhibited accelerated development of IR-induced osteosarcoma, with a latency of 39 weeks. Initial exposure of osteoblasts to carcinogenic doses of IR in vitro and in vivo induced RB1-dependent senescence and the expression of a panel of proteins known as senescence-associated secretory phenotype (SASP), dominated by IL-6. RB1 expression closely correlated with that of the SASP cassette in human osteosarcomas, and low expression of both RB1 and the SASP genes was associated with poor prognosis. In vivo, IL-6 was required for IR-induced senescence, which elicited NKT cell infiltration and a host inflammatory response. Mice lacking IL-6 or NKT cells had accelerated development of IR-induced osteosarcomas. These data elucidate an important link between senescence, which is a cell-autonomous tumor suppressor response, and the activation of host-dependent cancer immunosurveillance. Our findings indicate that overcoming the immune response to senescence is a rate-limiting step in the formation of IR-induced osteosarcoma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24231354      PMCID: PMC3859382          DOI: 10.1172/JCI70559

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  64 in total

1.  Radiation-induced osteosarcoma after bilateral childhood retinoblastoma.

Authors:  L L Chan; B A Czerniak; L E Ginsberg
Journal:  AJR Am J Roentgenol       Date:  2000-05       Impact factor: 3.959

2.  The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation.

Authors:  D M Thomas; S A Carty; D M Piscopo; J S Lee; W F Wang; W C Forrester; P W Hinds
Journal:  Mol Cell       Date:  2001-08       Impact factor: 17.970

Review 3.  Osteosarcoma following retinoblastoma: age at onset and latency period.

Authors:  L Chauveinc; V Mosseri; E Quintana; L Desjardins; P Schlienger; F Doz; B Dutrillaux
Journal:  Ophthalmic Genet       Date:  2001-06       Impact factor: 1.803

4.  Incidence of bone and soft tissue sarcoma after radiotherapy: a cohort study of 295,712 Finnish cancer patients.

Authors:  Anna Virtanen; Eero Pukkala; Anssi Auvinen
Journal:  Int J Cancer       Date:  2006-02-15       Impact factor: 7.396

5.  Requirement for Valpha14 NKT cells in IL-12-mediated rejection of tumors.

Authors:  J Cui; T Shin; T Kawano; H Sato; E Kondo; I Toura; Y Kaneko; H Koseki; M Kanno; M Taniguchi
Journal:  Science       Date:  1997-11-28       Impact factor: 47.728

Review 6.  Neutrophils in anti-cancer immunological strategies: old players in new games.

Authors:  E di Carlo; M Iezzi; T Pannellini; F Zaccardi; A Modesti; G Forni; P Musiani
Journal:  J Hematother Stem Cell Res       Date:  2001-12

7.  Interleukin-12 up-regulates Fas expression in human osteosarcoma and Ewing's sarcoma cells by enhancing its promoter activity.

Authors:  Zhichao Zhou; Elizabeth A Lafleur; Nadezhda V Koshkina; Laura L Worth; Malisa S Lester; Eugenie S Kleinerman
Journal:  Mol Cancer Res       Date:  2005-12       Impact factor: 5.852

8.  MIP-2 recruits NKT cells to the spleen during tolerance induction.

Authors:  D E Faunce; K H Sonoda; J Stein-Streilein
Journal:  J Immunol       Date:  2001-01-01       Impact factor: 5.422

9.  Requirement for p27(KIP1) in retinoblastoma protein-mediated senescence.

Authors:  K Alexander; P W Hinds
Journal:  Mol Cell Biol       Date:  2001-06       Impact factor: 4.272

10.  Phenotypic and functional analysis of lymphocytes infiltrating osteolytic tumors: use as a possible therapeutic approach of osteosarcoma.

Authors:  S Théoleyre; K Mori; B Cherrier; N Passuti; F Gouin; F Rédini; D Heymann
Journal:  BMC Cancer       Date:  2005-09-27       Impact factor: 4.430

View more
  26 in total

Review 1.  Bone microenvironment signals in osteosarcoma development.

Authors:  Arantzazu Alfranca; Lucia Martinez-Cruzado; Juan Tornin; Ander Abarrategi; Teresa Amaral; Enrique de Alava; Pablo Menendez; Javier Garcia-Castro; Rene Rodriguez
Journal:  Cell Mol Life Sci       Date:  2015-05-03       Impact factor: 9.261

2.  dNTP metabolism links mechanical cues and YAP/TAZ to cell growth and oncogene-induced senescence.

Authors:  Giulia Santinon; Irene Brian; Arianna Pocaterra; Patrizia Romani; Elisa Franzolin; Chiara Rampazzo; Silvio Bicciato; Sirio Dupont
Journal:  EMBO J       Date:  2018-04-12       Impact factor: 11.598

3.  Age-associated inflammation connects RAS-induced senescence to stem cell dysfunction and epidermal malignancy.

Authors:  L Golomb; A Sagiv; I S Pateras; A Maly; V Krizhanovsky; V G Gorgoulis; M Oren; A Ben-Yehuda
Journal:  Cell Death Differ       Date:  2015-03-20       Impact factor: 15.828

4.  Expression and clinical significance of cyclooxygenase-2 and microRNA-143 in osteosarcoma.

Authors:  Yongchao Fang; Zhiqiang Zhang; Qiang Wang; Jianning Zhao
Journal:  Exp Ther Med       Date:  2015-04-14       Impact factor: 2.447

Review 5.  Cancer prevention and therapy through the modulation of the tumor microenvironment.

Authors:  Stephanie C Casey; Amedeo Amedei; Katia Aquilano; Asfar S Azmi; Fabian Benencia; Dipita Bhakta; Alan E Bilsland; Chandra S Boosani; Sophie Chen; Maria Rosa Ciriolo; Sarah Crawford; Hiromasa Fujii; Alexandros G Georgakilas; Gunjan Guha; Dorota Halicka; William G Helferich; Petr Heneberg; Kanya Honoki; W Nicol Keith; Sid P Kerkar; Sulma I Mohammed; Elena Niccolai; Somaira Nowsheen; H P Vasantha Rupasinghe; Abbas Samadi; Neetu Singh; Wamidh H Talib; Vasundara Venkateswaran; Richard L Whelan; Xujuan Yang; Dean W Felsher
Journal:  Semin Cancer Biol       Date:  2015-04-10       Impact factor: 15.707

Review 6.  Opportunities and challenges of radiotherapy for treating cancer.

Authors:  Dörthe Schaue; William H McBride
Journal:  Nat Rev Clin Oncol       Date:  2015-06-30       Impact factor: 66.675

7.  Pro- and anti-tumorigenic functions of the senescence-associated secretory phenotype.

Authors:  Lena Lau; Gregory David
Journal:  Expert Opin Ther Targets       Date:  2019-01-15       Impact factor: 6.902

Review 8.  Molecular genetics of osteosarcoma.

Authors:  Kirby Rickel; Fang Fang; Jianning Tao
Journal:  Bone       Date:  2016-10-17       Impact factor: 4.398

Review 9.  Translational biology of osteosarcoma.

Authors:  Maya Kansara; Michele W Teng; Mark J Smyth; David M Thomas
Journal:  Nat Rev Cancer       Date:  2014-10-16       Impact factor: 60.716

Review 10.  Radiation-Induced Immunity and Toxicities: The Versatility of the cGAS-STING Pathway.

Authors:  Julie Constanzo; Julien Faget; Chiara Ursino; Christophe Badie; Jean-Pierre Pouget
Journal:  Front Immunol       Date:  2021-05-17       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.